Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 2/20 | 0.55 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.52 |
| ▸ | ITGAV | P06756 | 7/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.52 |
| ▸ | ITGB5 | P18084 | 2/20 | 0.52 |
| ▸ | ITGB6 | P18564 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6805505 | 0.95 | CASR (0.50) | CASRITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6545853 | 0.95 | ITGAV (0.58) | CASRITGB3ITGAVITGA2BITGB5 | |
| Trifluoroacetic Acid SCHEMBL6806858 | 0.91 | ITGAV (0.53) | CASRITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6545220 | 0.90 | CASR (0.53) | CASRITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6805508 | 0.88 | CASR (0.48) | CASRITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6545294 | 0.88 | ITGB3 (0.59) | CASRITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6546550 | 0.86 | ITGB3 (0.54) | CASRITGB3ITGAVITGA2BITGB5 | |
| Trifluoroacetic Acid SCHEMBL6804033 | 0.85 | ITGB3 (0.48) | CASRITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6802152 | 0.85 | ITGB3 (0.53) | CASRITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6546023 | 0.85 | ITGB3 (0.58) | CASRITGB3ITGAVITGA2BITGB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142877-A1 | Ligands of the $g(a)v$g(b)6 integrin | MERCK PATENT GMBH (DE) | 2004-07-22 | — | — | US | claimed |
| EP-1379495-A2 | LIGANDS OF THE ALPHA-V-BETA 6 INTEGRIN | MERCK PATENT GmbH (DE) | 2004-01-14 | — | — | EP | claimed |
| WO-2002083627-A2 | LIGANDS DES INTEGRINS AVSS6 | MERCK PATENT GMBH (DE) | 2002-10-24 | — | — | WO | claimed |
| US-20040142877-A1 | Ligands of the $g(a)v$g(b)6 integrin | MERCK PATENT GMBH (DE) | 2004-07-22 | — | — | US | disclosed |
| EP-1379495-A2 | LIGANDS OF THE ALPHA-V-BETA 6 INTEGRIN | MERCK PATENT GmbH (DE) | 2004-01-14 | — | — | EP | disclosed |
| WO-2002083627-A2 | LIGANDS DES INTEGRINS AVSS6 | MERCK PATENT GMBH (DE) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142877-A1 | Ligands of the $g(a)v$g(b)6 integrin | ITGB6, ITGAV, ITGB1 | CASR 954/4885ITGB3 13/4885ITGAV 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.